Nelly Aranı́bar

Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165

Stephen T. Wrobleski, Ryan Moslin, Shuqun Lin et al. · Journal of Medicinal Chemistry · 2019 · 369 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease

April D. Lake, Petr Novák, Petia Shipkova et al. · Amino Acids · 2014 · 233 citations · Full text

Medicine, Biochemistry, Molecular Medicine +10

Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease

April D. Lake, Petr Novák, Petia Shipkova et al. · Toxicology and Applied Pharmacology · 2013 · 190 citations

Life Sciences, Biochemistry, Toxicology +14

Metabonomics classifies pathways affected by bioactive compounds. Artificial neural network classification of NMR spectra of plant extracts

Karl‐Heinz Ott, Nelly Aranı́bar, Bijay Singh et al. · Phytochemistry · 2003 · 163 citations

Life Sciences, Bioinformatics, Plant Sciences +17

Identification of <i>N</i>-Methyl Nicotinamide and <i>N</i>-Methyl Pyridazine-3-Carboxamide Pseudokinase Domain Ligands as Highly Selective Allosteric Inhibitors of Tyrosine Kinase 2 (TYK2)

Ryan Moslin, Yanlei Zhang, Stephen T. Wrobleski et al. · Journal of Medicinal Chemistry · 2019 · 92 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17